Folcasin IM/IV Injection

Folinic Acid 10 mg/ml BOTS Pvt. Limited 100 mg vial: ৳ 1,477.00 Indications Folcasin is indicated in: Composition Each tablet contains- Pharmacology This is the preparation of Calcium Folinate Hydrate which is calcium salt of folinic acid (5-formyl derivative of tetrahydrofolic acid). It is a metabolite and active form of folic acid that is involved as […]

Episindan IV Infusion

Epirubicin Hydrochloride 2 mg/ml BOTS Pvt. Limited 10 mg vial: ৳ 915.00 50 mg vial: ৳ 1,990.00 Indications Episindan Injection is indicated as a component of adjuvant therapy in patients with evidence of axillary node tumor involvement following resection of primary breast cancer. Pharmacology Epirubicin Hydrochloride, an anthracycline with cytotoxic properties. It inhibits DNA and RNA synthesis […]

Docetaxel Axios IV Infusion

Docetaxel Trihydrate 80 mg/vial BOTS Pvt. Limited 80 mg vial: ৳ 11,370.00 Indications Docetaxel Axios is a microtubule inhibitor indicated for: Pharmacology Docetaxel is an antineoplastic agent, which acts by disrupting the microtubular network in cells that is essential for vital mitotic and interphase cellular functions. Docetaxel promotes the assembly of tubulin into stable microtubules while […]

Docetaxel Axios IV Infusion

Docetaxel Trihydrate 20 mg/vial BOTS Pvt. Limited 20 mg vial: ৳ 4,400.00 Indications Docetaxel Axios is a microtubule inhibitor indicated for: Pharmacology Docetaxel is an antineoplastic agent, which acts by disrupting the microtubular network in cells that is essential for vital mitotic and interphase cellular functions. Docetaxel promotes the assembly of tubulin into stable microtubules while […]

Carboplatin Sindan IV Infusion

Carboplatin 10 mg/ml BOTS Pvt. Limited 450 mg vial: ৳ 4,140.00 800 mg vial: ৳ 5,520.00 Indications Carboplatin Sindan Sindan Injection is indicated for the initial treatment of advanced ovarian carcinoma of epithelial origin in established combination with other approved chemotherapeutic agents. It is also indicated for the palliative treatment of patient with ovarian carcinoma recurrent after […]